Skip to main content
LEMAITRE VASCULAR INC logo

LEMAITRE VASCULAR INC — Investor Relations & Filings

Ticker · LMAT ISIN · US5255582018 LEI · 549300FZUBUB7MHY8R17 US Manufacturing
Open in API
Filings indexed 1,500 across all filing types
Latest filing 2026-06-04 Declaration of Voting R…
Country US United States of America
Listing US LMAT

About LEMAITRE VASCULAR INC

https://www.lemaitre.com/

LeMaitre Vascular, Inc. is a medical device company that develops, manufactures, and markets disposable and implantable devices for the treatment of peripheral vascular disease. The company's products are utilized by vascular surgeons and interventionalists for procedures involving arteries and veins outside the heart. The portfolio supports a range of applications, including open vascular surgery, endovascular therapies, the creation and maintenance of dialysis access sites, and the treatment of varicose veins. In addition to its device offerings, the company provides human tissue cryopreservation services. A key product is the LeMaitre® Valvulotome, an instrument used for in situ bypass procedures.

Recent filings

Filing Released Lang Actions
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 88% confidence The document is a current report on Form 8-K filed with the SEC, containing the detailed voting results from the company’s 2026 Annual Meeting of Stockholders under Item 5.07 (“Submission of Matters to a Vote of Security Holders”). It lists each proposal and the vote tallies. This matches the definition of "Declaration of Voting Results & Voting Rights Announcements".
2026-06-04 English
SD
Regulatory Filings Classification · 93% confidence The document is the full text of a Form SD “Specialized Disclosure Report” filed with the SEC containing conflict minerals disclosure under Rule 13p-1. It is a regulatory compliance filing, not an annual or interim financial report, earnings release, management discussion, or proxy material. There is no presentation or issuance of shares; it is a standalone SEC disclosure. Therefore it falls into the general Regulatory Filings category (RNS).
2026-05-29 English
10-Q - LEMAITRE VASCULAR INC (0001158895) (Filer)
Interim / Quarterly Report Q1 2026
2026-05-06 English
8-K - LEMAITRE VASCULAR INC (0001158895) (Filer)
Regulatory Filings Classification · 90% confidence The document is a Form 8-K current report filed with the U.S. SEC, containing Item 2.02 (Results of Operations and Financial Condition) and furnishing a press release as an exhibit. It is a general regulatory announcement under the Securities Exchange Act and does not itself present full financial statements like an interim or annual report. Under the taxonomy, a Form 8-K falls into the Regulatory Filings category.
2026-05-05 English
DEF 14A - LEMAITRE VASCULAR INC (0001158895) (Filer)
Proxy Solicitation & Information Statement
2026-04-14 English
8-K - LEMAITRE VASCULAR INC (0001158895) (Filer)
Board/Management Information Classification · 100% confidence The document is a Form 8-K current report filed with the SEC, dated April 8, 2026. The content focuses on the departure of a director (Bridget Ross) and the nomination and conditional resignation of another director (David B. Roberts) to rebalance the board classes. It also mentions the reduction of the board size from eight to seven members. There are no financial statements or detailed financial data presented. The primary subject is changes in the company's board of directors. According to the filing definitions, announcements of changes in the company's board of directors or senior management fall under Board/Management Information (MANG). The document is not an annual report, earnings release, or any other financial report type. Therefore, the correct classification is MANG with high confidence.
2026-04-14 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.